We think differently about mental health so you can too
Our vision is a world of mental wellbeing.
COMPASS is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first programme is researching how COMP360 psilocybin therapy could help people with treatment-resistant depression.
We want to transform the patient experience in mental health care.
Everyone has a mental health story, be it their own, or that of a friend or loved one. Our people bring their stories, and a wide range of backgrounds and skills to COMPASS.
Our research is evidence-based and underpinned by a commitment to find better ways to support and empower people suffering with poor mental health.
News & views
Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology, and digital platforms.
Data demonstrating long-term improvement in depression in cancer patients following single dose of COMP360 psilocybin therapy to be presented at ASCO 2023
COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights
American Medical Association to Issue First New Code for Psychedelic Therapies